{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:31:29Z","timestamp":1785547889581,"version":"3.56.0"},"reference-count":87,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2023,10,4]]},"DOI":"10.18632\/oncotarget.28518","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T12:44:46Z","timestamp":1696423486000},"page":"860-877","source":"Crossref","is-referenced-by-count":6,"title":["Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity"],"prefix":"10.18632","volume":"14","author":[{"given":"Gulnur","family":"Zhunussova","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"},{"name":"Al-Farabi Kazakh National University, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazgul","family":"Omarbayeva","sequence":"additional","affiliation":[{"name":"Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan"},{"name":"Asfendiyarov Kazakh National Medical University, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilyara","family":"Kaidarova","sequence":"additional","affiliation":[{"name":"Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan"},{"name":"Asfendiyarov Kazakh National Medical University, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saltanat","family":"Abdikerim","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"},{"name":"Al-Farabi Kazakh National University, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalya","family":"Mit","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Kisselev","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanagat","family":"Yergali","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigul","family":"Zhunussova","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Goncharova","sequence":"additional","affiliation":[{"name":"Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Abdrakhmanova","sequence":"additional","affiliation":[{"name":"Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan"},{"name":"Asfendiyarov Kazakh National Medical University, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Djansugurova","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan"},{"name":"Al-Farabi Kazakh National University, Almaty 050060, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.31557\/APJCP.2023.24.3.1037","article-title":"Study on Breast Cancer in Kazakhstan Using the Functional Time Series","volume":"2","author":"Zharmenov","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.52532\/1-11-2021-1-384","article-title":"The indicators of the Oncology Service of the Republic of Kazakhstan, 2021 (Statistical and Analytical Materials)\/eds","author":"Sagi","year":"2022","journal-title":"KIOR JSC"},{"key":"3","doi-asserted-by":"publisher","first-page":"e213","DOI":"10.1097\/j.pbj.0000000000000213","article-title":"Breast cancer in young women: a rising threat: A 5-year follow-up comparative study","volume":"8","author":"Pinto-de-Sousa","year":"2023","journal-title":"Porto Biomed J"},{"key":"4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.20471\/acc.2018.57.03.13","article-title":"Breast cancer in young women: pathologic and immunohistochemical features","volume":"5","author":"Babi\u0107","year":"2018","journal-title":"Acta Clin Croat"},{"key":"5","doi-asserted-by":"publisher","first-page":"740227","DOI":"10.3389\/fonc.2021.740227","article-title":"Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population","volume":"1","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.currproblcancer.2016.09.007","article-title":"Genetics of triple-negative breast cancer: Implications for patient care","volume":"4","author":"Kurian","year":"2016","journal-title":"Curr Probl Cancer"},{"key":"7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2018_147","article-title":"The BRCA1 and BRCA2 Genes in Early-Onset Breast Cancer Patients","volume":"129","author":"Yahaya","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1200\/JCO.21.00999","article-title":"Management of Women With Breast Cancer and Pathogenic Variants in Genes Other Than BRCA1 or BRCA2","volume":"3","author":"Robson","year":"2021","journal-title":"J Clin Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/medicina56100514","article-title":"Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans","volume":"5","author":"Park","year":"2020","journal-title":"Medicina (Kaunas)"},{"key":"10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ejhg.2008.212","article-title":"Breast cancer susceptibility: current knowledge and implications for genetic counselling","volume":"1","author":"Schlegelberger","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"11","volume-title":"StatPearls","author":"Regan","year":"2023"},{"key":"12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1200\/JCO.22.01239","article-title":"Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2","volume":"4","author":"Patel","year":"2023","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/ijc.32385","article-title":"Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer","volume":"14","author":"Soukupova","year":"2019","journal-title":"Int J Cancer"},{"key":"14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3390\/genes12050727","article-title":"The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice","volume":"1","author":"Porta","year":"2021","journal-title":"Genes (Basel)"},{"key":"15","doi-asserted-by":"publisher","first-page":"17588359221122725","DOI":"10.1177\/17588359221122725","article-title":"Clinical validity and clinical utility of Ki67 in early breast cancer","volume":"1","author":"Christgen","year":"2022","journal-title":"Ther Adv Med Oncol"},{"key":"16","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"46","author":"McVean","year":"2010","journal-title":"Nature"},{"key":"17","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","article-title":"Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm","volume":"4","author":"Ng","year":"2009","journal-title":"Nat Protoc"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1002\/0471142905.hg0720s76","article-title":"Predicting functional effect of human missense mutations using PolyPhen-2","volume":"Chapter 7","author":"Sunyaev","year":"2013","journal-title":"Curr Protoc Hum Genet"},{"key":"19","first-page":"155","article-title":"Gene Panel Testing in Hereditary Breast Cancer","volume":"2","author":"Sanati","year":"2020","journal-title":"Arch Iran Med"},{"key":"20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","article-title":"A Population-Based Study of Genes Previously Implicated in Breast Cancer","volume":"38","author":"Ambrosone","year":"2021","journal-title":"N Engl J Med"},{"key":"21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/jmedgenet-2019-106189","article-title":"One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene","volume":"5","author":"Vlachos","year":"2020","journal-title":"J Med Genet"},{"key":"22","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S1470-2045(22)00378-3","article-title":"Call for action: expanding global access to hereditary cancer genetic testing","volume":"2","author":"Sandoval","year":"2022","journal-title":"Lancet Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/jhg.2016.4","article-title":"Detection of high frequency of mutations in a breast and\/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India","volume":"6","author":"Ramamurthy","year":"2016","journal-title":"J Hum Genet"},{"key":"24","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1038\/s41598-022-07383-1","article-title":"Detection of germline variants in Brazilian breast cancer patients using multigene panel testing","volume":"1","author":"Folgueira","year":"2022","journal-title":"Sci Rep"},{"key":"25","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.3390\/cancers12113140","article-title":"NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases","volume":"1","author":"Hadjisavvas","year":"2020","journal-title":"Cancers (Basel)"},{"key":"26","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"12","author":"Daly","year":"2017","journal-title":"Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10549-018-4726-x","article-title":"Screening of over 1000 Indian patients with breast and\/or ovarian cancer with a multi-gene panel: prevalence of BRCA1\/2 and non-BRCA mutations","volume":"17","author":"Chakraborti","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jmoldx.2015.04.009","article-title":"A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients","volume":"1","author":"Ellisen","year":"2015","journal-title":"J Mol Diagn"},{"key":"29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10549-015-3429-9","article-title":"HBOC multi-gene panel testing: comparison of two sequencing centers","volume":"15","author":"Wimberger","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/gim.2015.166","article-title":"Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing","volume":"1","author":"Pineda-Alvarez","year":"2016","journal-title":"Genet Med"},{"key":"31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer","volume":"3","author":"Garber","year":"2016","journal-title":"J Clin Oncol"},{"key":"32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/gim.2017.96","article-title":"Racial\/ethnic differences in multiple-gene sequencing results for hereditary cancer risk","volume":"2","author":"Kurian","year":"2018","journal-title":"Genet Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s10038-020-0729-7","article-title":"Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors","volume":"6","author":"You","year":"2020","journal-title":"J Hum Genet"},{"key":"34","doi-asserted-by":"publisher","first-page":"10514","DOI":"10.1200\/JCO.2022.40.16_suppl.10514","article-title":"Double jeopardy? A closer look at cancer histories of individuals with multiple germline pathogenic variants","volume":"4","author":"Rana","year":"2022","journal-title":"J Clin Oncol"},{"key":"35","first-page":"NBK541231","volume-title":"GeneReviews","author":"Pagon","year":"1993"},{"key":"36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cancergen.2019.06.006","article-title":"Prevalence and founder effect of the BRCA1 p.(Val1833Met) variant in the Greek population, with further evidence for pathogenicity and risk modification","volume":"23","author":"Konstantopoulou","year":"2019","journal-title":"Cancer Genet"},{"key":"37","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1002\/ijc.32877","article-title":"BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients","volume":"14","author":"Xie","year":"2020","journal-title":"Int J Cancer"},{"key":"38","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1002\/ijc.32492","article-title":"The spectrum of mutations predisposing to familial breast cancer in Poland","volume":"14","author":"Lener","year":"2019","journal-title":"Int J Cancer"},{"key":"39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10549-022-06557-9","article-title":"Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews","volume":"19","author":"Lagovsky","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"40","doi-asserted-by":"publisher","first-page":"e57173","DOI":"10.1371\/journal.pone.0057173","article-title":"Comparativeand in silico analyses of variants in splicing regions of BRCA1 and BRCA2 genes and characterization of novel pathogenic mutations","volume":"8","author":"Radice","year":"2013","journal-title":"PLoS One"},{"key":"41","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1002\/humu.23842","article-title":"The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries","volume":"4","author":"Plaseska-Karanfilska","year":"2019","journal-title":"Hum Mutat"},{"key":"42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12885-022-09181-4","article-title":"Prevalence of specific and recurrent\/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa","volume":"2","author":"Ennaji","year":"2022","journal-title":"BMC Cancer"},{"key":"43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5195\/cajgh.2016.228","article-title":"The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan","volume":"5","author":"Turdikulova","year":"2016","journal-title":"Cent Asian J Glob Health"},{"key":"44","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/ijc.34359","article-title":"Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population","volume":"15","author":"Zhang","year":"2023","journal-title":"Int J Cancer"},{"key":"45","doi-asserted-by":"publisher","first-page":"vi43","DOI":"10.1093\/annonc\/mdw364.26","article-title":"Germline BRCA screening in breast cancer patients in Tatar women population","volume":"2","author":"Gordiev","year":"2016","journal-title":"Ann Oncol"},{"key":"46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.breast.2012.12.007","article-title":"BRCA1 gene mutations frequency estimation by allele-specific real-time PCR of pooled genomic DNA samples","volume":"2","author":"Kovalenko","year":"2013","journal-title":"Breast"},{"key":"47","first-page":"58","article-title":"The prevalence of some polymorphisms in the BRCA1 and BRCA2 genes in breast cancer among the population of the Republic of Kazakhstan","volume":"4","author":"Aithojina","year":"2012","journal-title":"Reports of the National Academy of Sciences of the Republic of Kazakhstan"},{"key":"48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5195\/cajgh.2013.29","article-title":"BRCA1 and BRCA2 Gene Mutations Screening In Sporadic Breast Cancer Patients In Kazakhstan","volume":"2","author":"Momynaliev","year":"2013","journal-title":"Cent Asian J Glob Health"},{"key":"49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/humu.23406","article-title":"Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations","volume":"3","author":"Chan","year":"2018","journal-title":"Hum Mutat"},{"key":"50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3389\/fonc.2019.00673","article-title":"Mutation Spectrum of Cancer-Associated Genes in Patients With Early Onset of Colorectal Cancer","volume":"9","author":"Djansugurova","year":"2019","journal-title":"Front Oncol"},{"key":"51","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/bjc.2013.741","article-title":"Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study","volume":"11","author":"Singer","year":"2014","journal-title":"Br J Cancer"},{"key":"52","doi-asserted-by":"publisher","first-page":"7832","DOI":"10.18632\/oncotarget.23471","article-title":"Rapid detection of BRCA1\/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels","volume":"9","author":"Ma","year":"2018","journal-title":"Oncotarget"},{"key":"53","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10549-015-3377-4","article-title":"The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study","volume":"15","author":"Kim","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"54","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s10549-012-2001-0","article-title":"Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: the Korean Hereditary Breast Cancer (KOHBRA) Study","volume":"13","author":"Suh","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"55","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s10549-012-2159-5","article-title":"Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer","volume":"13","author":"Haffty","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4048\/jbc.2013.16.1.50","article-title":"Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China","volume":"1","author":"Upur","year":"2013","journal-title":"J Breast Cancer"},{"key":"57","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ijc.1626","article-title":"Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population","volume":"9","author":"Meindl","year":"2002","journal-title":"Int J Cancer"},{"key":"58","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1038\/srep04026","article-title":"Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status","volume":"4","author":"Konecny","year":"2014","journal-title":"Sci Rep"},{"key":"59","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10549-020-05827-8","article-title":"Frequency and spectrum of founder and non-founder BRCA1 and BRCA2 mutations in a large series of Russian breast cancer and ovarian cancer patients","volume":"18","author":"Stepanov","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"60","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.7314\/apjcp.2014.15.11.4513","article-title":"BRCA1 gene exon 11 mutations in Uighur and Han women with early-onset sporadic breast cancer in the northwest region of China","volume":"1","author":"Li","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"61","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.euo.2021.06.004","article-title":"Germline BRCA1 Mutation and Prostate Cancer: Be Careful on Causality","volume":"4","author":"Caron","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"62","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/genes13020321","article-title":"Pancreatic Cancer with Mutation in BRCA1\/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation","volume":"1","author":"Molinari","year":"2022","journal-title":"Genes (Basel)"},{"key":"63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13167-010-0037-y","article-title":"Founder BRCA1\/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control","volume":"1","author":"Janavi\u010dius","year":"2010","journal-title":"EPMA J"},{"key":"64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13053-015-0040-3","article-title":"The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine","volume":"1","author":"Kozeretska","year":"2015","journal-title":"Hered Cancer Clin Pract"},{"key":"65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1515\/tjb-2019-0424","article-title":"Spectrum of BRCA1\/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study","volume":"4","author":"Erdem","year":"2019","journal-title":"Turk J Biochem"},{"key":"66","doi-asserted-by":"publisher","first-page":"7113","DOI":"10.1007\/s11033-023-08588-x","article-title":"Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications","volume":"5","author":"Minucci","year":"2023","journal-title":"Mol Biol Rep"},{"key":"67","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.3390\/ijms21145036","article-title":"Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications","volume":"2","author":"Teixeira","year":"2020","journal-title":"Int J Mol Sci"},{"key":"68","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4137\/BCBCR.S18715","article-title":"Hereditary breast cancer: clinical, pathological and molecular characteristics","volume":"8","author":"Kruse","year":"2014","journal-title":"Breast Cancer (Auckl)"},{"key":"69","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnci\/djy106","article-title":"Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing","volume":"11","author":"Fasching","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"70","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ccr3.3548","article-title":"A pathogenic germline BRCA2 variant in a patient with hypopharyngeal squamous cell carcinoma","volume":"9","author":"Hoffman","year":"2021","journal-title":"Clin Case Rep"},{"key":"71","doi-asserted-by":"publisher","first-page":"64","DOI":"10.21037\/cco-2019-ddp-05","article-title":"BReast CAncer (BRCA) gene mutations as an emerging biomarker for the treatment of gastrointestinal malignancies","volume":"9","author":"O\u2019Reilly","year":"2020","journal-title":"Chin Clin Oncol"},{"key":"72","doi-asserted-by":"publisher","first-page":"565","DOI":"10.5306\/wjco.v12.i7.565","article-title":"BRCA mutations and gastrointestinal cancers: When to expect the unexpected?","volume":"1","author":"Berardi","year":"2021","journal-title":"World J Clin Oncol"},{"key":"73","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.3390\/cancers12113346","article-title":"BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives","volume":"1","author":"Rovesti","year":"2020","journal-title":"Cancers (Basel)"},{"key":"74","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.4143\/crt.2018.532","article-title":"Inherited NBN Mutations and Prostate Cancer Risk and Survival","volume":"5","author":"Cybulski","year":"2019","journal-title":"Cancer Res Treat"},{"key":"75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2021.10.036","article-title":"Inherited TP53 Variants and Risk of Prostate Cancer","volume":"8","author":"Vagher","year":"2022","journal-title":"Eur Urol"},{"key":"76","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41416-021-01410-0","article-title":"PALB2 mutations and prostate cancer risk and survival","volume":"12","author":"Domaga\u0142a","year":"2021","journal-title":"Br J Cancer"},{"key":"77","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.euo.2020.12.001","article-title":"Rare Germline Variants in ATM Predispose to Prostate Cancer: A PRACTICAL Consortium Study","volume":"4","author":"Teixeira","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/pros.23505","article-title":"A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer","volume":"7","author":"Brendler","year":"2018","journal-title":"Prostate"},{"key":"79","doi-asserted-by":"publisher","first-page":"2381468318821103","DOI":"10.1177\/2381468318821103","article-title":"The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway","volume":"4","author":"Melberg","year":"2019","journal-title":"MDM Policy Pract"},{"key":"80","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fonc.2015.00208","article-title":"Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management","volume":"5","author":"Weitzel","year":"2015","journal-title":"Front Oncol"},{"key":"81","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1111\/tbj.13971","article-title":"Update on multi-gene panel testing and communication of genetic test results","volume":"2","author":"Pal","year":"2020","journal-title":"Breast J"},{"key":"82","doi-asserted-by":"publisher","first-page":"220","DOI":"10.15386\/mpr-1083","article-title":"Multi gene panel testing for hereditary breast cancer - is it ready to be used?","volume":"9","author":"Antemie","year":"2019","journal-title":"Med Pharm Rep"},{"key":"83","unstructured":"Nomenclature for the description of sequence variants. Human Genome Variation Society. 2013. https:\/\/www.hgvs.org\/mutnomen."},{"key":"84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"2","author":"Mesirov","year":"2011","journal-title":"Nat Biotechnol"},{"key":"85","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"1","author":"Mesirov","year":"2013","journal-title":"Brief Bioinform"},{"key":"86","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"1","author":"Rehm","year":"2015","journal-title":"Genet Med"},{"key":"87","doi-asserted-by":"publisher","first-page":"8310","DOI":"10.18632\/oncotarget.7027","article-title":"Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer","volume":"7","author":"Hsu","year":"2016","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T12:45:11Z","timestamp":1696423511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,10,4]]}},"alternative-id":["28518"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28518","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]}}}